The short version: The most notable trial in this area studied 52 women with major depressive disorder, all taking the antidepressant escitalopram. Half also took 5 g of creatine daily. Over eight weeks, the creatine group improved faster and more substantially. It is a real finding with a large effect size — and it is one relatively small study of creatine as an add-on to prescribed treatment, not as a replacement for it. Broader reviews of the field describe results as mixed.
This is an area where accuracy matters more than enthusiasm, so we have tried to be precise about what has and has not been shown.
Why researchers looked at creatine for mood at all
The rationale comes from brain imaging rather than from supplement marketing. Studies using magnetic resonance spectroscopy have repeatedly found abnormalities in brain energy metabolism in people with major depression — differences in phosphocreatine and ATP dynamics in particular. Those abnormalities tend to normalize when treatment is successful.
That observation generated a straightforward hypothesis: if depression involves impaired brain bioenergetics, and creatine is the brain’s primary energy buffering system, supplementing creatine might support recovery.
There is a second reason researchers focused on women specifically. Women have lower baseline brain creatine concentrations than men in some measurements, experience major depression at roughly twice the rate, and are more likely to have treatment-resistant presentations. If creatine’s benefit depends on baseline depletion — the pattern seen across the broader creatine literature — women would be the logical group to test.
The landmark trial
Published in the American Journal of Psychiatry in 2012 by Lyoo and colleagues, this remains the most cited study in the field.
Design: 52 women diagnosed with major depressive disorder. All received escitalopram, a standard SSRI. Participants were randomized to also receive either 5 g/day of creatine monohydrate (25 women) or placebo (27 women). Double-blind, eight weeks.
Results: The creatine group showed significantly greater improvement on the Hamilton Depression Rating Scale than the placebo group. A later analysis calculated the effect size at approximately d = 1.13 — a large effect by conventional standards. Notably, the separation between groups appeared early, by week two, suggesting faster onset rather than only a better endpoint.
The speed finding is clinically interesting on its own. One of the hardest parts of starting an antidepressant is the multi-week lag before it works, a window when many people stop taking it. Anything that shortens that gap is worth studying.
The important caveats
This is one study of 52 people. Large effect sizes in small trials are exactly where replication problems tend to appear. A single well-designed trial establishes that something is worth investigating further. It does not establish a treatment.
Everyone in it was on an antidepressant. Creatine was tested as augmentation — added on top of prescribed care. The trial says nothing about creatine as a standalone approach to depression, and it was not designed to.
The broader literature is mixed. Subsequent reviews of creatine and depression describe inconsistent findings across studies. A 2024 pilot trial testing creatine alongside cognitive behavioural therapy in an under-resourced setting explored a different delivery model with its own preliminary results, and work in bipolar depression has produced separate and more complicated findings. Enthusiasm should be calibrated to a field in progress.
Sex-specific superiority isn’t established. Although the landmark trial was in women, reviewers have not found a clear signal that creatine works better in women than men for mood. The women-specific focus reflects study design, not proven differential response.
What the women’s health literature says about mood more broadly
Beyond clinical depression, the 2025 review of creatine across the female lifespan flags mood as an emerging area of interest, particularly around the menstrual cycle. The proposed mechanism: hormone-driven changes in neurotransmitter activity across the cycle increase brain energy demand, and creatine may help buffer that demand during the phases when mood disturbance is most common.
This is early. It is a coherent hypothesis supported by mechanism and some preliminary work, not a demonstrated effect. The same review calls for more research here rather than declaring the question answered.
The overlap with the cognition research is worth noticing. Both areas point in the same direction — creatine supports brain energy availability, and the benefit is most detectable when the system is under strain. Mood and cognition may be two views of one underlying mechanism.
How to think about this if you’re researching creatine
Creatine is not a treatment for depression. It has been studied as a low-cost, well-tolerated addition to established treatment. If you are experiencing depression, the intervention with strong evidence behind it is care from a qualified provider — therapy, medication, or both.
If you’re already in treatment, this is a reasonable conversation to have. Creatine at 5 g/day is inexpensive and has a well-characterized safety profile. Bringing this research to your prescriber is a legitimate thing to do. Do not add it silently to a psychiatric medication regimen — your provider should know everything you take, and that principle holds regardless of how benign a supplement appears.
Set expectations at the level of the evidence. If you take creatine for muscle, bone, or training reasons and find your mood is a little steadier, that is consistent with the research. Expecting a supplement to resolve a mood disorder is not.
Note the dose. The mood research used 5 g/day, at the upper end of the standard 3–5 g range rather than above it. That is convenient: the dose studied for mood is the same dose used for everything else.
Frequently asked questions
Can creatine replace my antidepressant? No. Every trial in this area studied creatine added to existing treatment, not instead of it. Do not stop or change prescribed medication without your prescriber’s involvement.
What dose was used in the research? 5 g per day of creatine monohydrate, taken alongside standard treatment for eight weeks.
Does creatine help with PMS or premenstrual mood changes? The mechanism is plausible and the 2025 lifespan review identifies it as an area of interest, but it has not been established in trials designed to test it.
Is it safe to take creatine with psychiatric medication? Creatine has a strong general safety record and no widely recognized interactions with common antidepressants, but “no known interaction” is not the same as clearance for your specific situation. Ask your prescriber.
If you are struggling with your mental health, please reach out to a healthcare provider or a trusted person in your life. A supplement is not a substitute for support, and support is worth asking for.
Read next
- The master research summary: everything the evidence says about creatine for women
- Creatine and brain fog: the sleep deprivation research
- Creatine across the female lifespan: the 2025 review
- Is creatine safe for women?
New to creatine? Start with our complete creatine guide for women.
Sources
- Lyoo IK, Yoon S, Kim TS, et al. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder. American Journal of Psychiatry. 2012;169(9):937-945. PubMed · Full text
- Efficacy and safety profile of oral creatine monohydrate in add-on to cognitive-behavioural therapy in depression: an 8-week pilot, double-blind, randomised, placebo-controlled feasibility and exploratory trial. European Neuropsychopharmacology. 2024. ScienceDirect
- Toniolo RA, Silva M, Fernandes FBF, Amaral JAMS, Dias RS, Lafer B. A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression. Journal of Neural Transmission. 2018;125(2):247-257. PMC
- Smith-Ryan AE, et al. Creatine in women’s health: bridging the gap from menstruation through pregnancy to menopause. JISSN. 2025;22(1):2502094. PubMed
Educational information only. This article summarizes published research and is not medical advice, and creatine is not a treatment for any mental health condition. Talk to your healthcare provider before adding any supplement to a treatment plan.
Leave a Reply